Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-21

FDA Approved: OXCARBAZEPINE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves Chartwell RX, LLC's original generic oxcarbazepine for treatment of partial seizures in adults and children with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)